Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy

Direct oral anticoagulants (DOACs) are used to prevent and treat thrombosis and thromboembolic events in patients with various diseases. Despite its high efficacy and safety, DOAC therapy is accompanied by increased risk of hemorrhage, including gastrointestinal bleeding. Bleeding risk depends on in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	N. V. Bakulina, S. V. Tikhonov, N. B. Lishchuk, A. B. Karaya
Formato:	Artigo
Idioma:	Russo
Publicado em:	«FIRMA «SILICEA» LLC 2021-09-01
coleção:	Российский кардиологический журнал
Assuntos:	anticoagulants direct oral anticoagulants rivaroxoban bleeding gastrointestinal bleeding proton pump inhibitors
Acesso em linha:	https://russjcardiol.elpub.ru/jour/article/view/4635
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!